Of The Worlds biggest crypto exchanges explains why its crucial The Worlds biggest economy makes the crypto rules clearer. And well hear from the man overseeing them. The head of the us regulator, the securities and Exchange Commission, explains why hes brought so many lawsuits against crypto firms. Plus, the viability of vaping. The boss of the E Cigarette Firm juul tells us why his business has a long term future, even though he doesnt want any young people taking up the habit. Wherever yourejoining me from around The World, hello, and welcome to the show. The us election is looming large, and there are many issues on voters minds, from inflation and climate change to war in the middle east. But despite all those, one republican senator has said that cryptocurrencies are a defining issue in the run up to november the 5th. And hes not alone in thinking that. The place of one of The Worlds most divisive and consequential technologies in The Worlds biggest economy is at stake, after a y
As the us exchanges open here in new york. Lets cross live now to Shams Afzal, Managing Director at carnegie investment counsel. Of course, in the last hour, we had that adp data out. How are the markets reacting to this . I think this number, as well as tomorrows total data will probably not change the narrative that has been set already that the Jobs Market has softened quite a bit compared to a year ago. I think the more important data that came out earlier showed the number ofjobs available. If number of jobs available. If you number ofjobs available. If you went back to february 2023, there were almost two jobs open every Wedding Work out there, now that number has shrunk to every 1. 1 jobs to every willing work out there. They are finally getting these numbers so this put the Rate Cut Regime very much intact starting from september and that will be on benefit to the overall capital markets. . Benefit to the overall capital markets. ,. , benefit to the overall capital markets. . ,
Good morning, everyone. Welcome to bloomberg surveillance. I am Francine Lacqua here in london. A lot going on, because we have Christine Lagarde testifying in parliament. We will bring you anything that comes out of it. The markets focusing on infections rising around the world. They are focusing around the fact that we could see a stimulus. Lets get to the markets. I dont know if we have them. If we do, it could be great, and it would be a good time to look at them. Overall,ok at stocks they are falling along u. S. Futures, tougher restrictions, progress toward a vaccine. We have plenty more of course on that. Astrazeneca at rising amidst positive news on its coronavirus vaccine. We are hearing from Christine Lagarde. We had an exclusive conversation days ago. The focus is on the need for a stimulus. The focus is also on the need for markets to do a little bit more. She said basically the ecb delivered in the first wave. She is talking about the physical packages, on course for a fis
Worked so much in the first couple of quarters. We are also expecting our investment ipo tomorrow. It is a very, very busy year for us, all in all. You are looking at health care opportunities. Everybody else seems to be doing that. That is why valuations have skyrocketed. What are you finding and what are you concentrating on within that space in particular . Nisa it is interesting. Board. St across the is, is really interesting when we invested in the first company, the first Vaccine Company to list in hong kong. One of our Companies Went out in hong kong, the first device company. Venus, thepo of whole medical device sector has become hot this year. Seen 25 areas we have Companies Getting funded in china alone. I am not sure about the competition. On the discovery side there is also excitement. Because valuation has grown so much, we would still stay away from very expensive deals. Historically, we have been investing 75 at least. Systematically we have been doing the same thing as
France threatens to get out of the rescue plan altogether. 11,000 jobs slashed, the german giant fights for survival. Welcome to the program. Looking at the futures, reflecting the way the european and u. S. Equity markets closed yesterday. Futures down in europe, mixed in the u. S. , reflecting what we saw yesterday were the u. S. Wobbled into the close at the end of the session. New york schools closing seems to be the factor. Breaking news, some commentary from astrazeneca in connection phasehase two, not the three news we have been waiting for. That is expected to come within weeks. This is more detail on the phase two data. They are confirming the vaccines immune response in older adults, that is crucial considering who is most vulnerable to the virus. The lancet is publishing the findings. A lot of stuff we have heard already from phase three trials more advanced than this from other drug companies. It has not been peerreviewed or in journals. We are getting the phase two study,